Free Trial

FitLife Brands (FTLF) Competitors

FitLife Brands logo
$14.10 +0.49 (+3.60%)
As of 07/3/2025 01:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FTLF vs. ATAI, ZVRA, TYRA, MAZE, VALN, SEPN, ATYR, MREO, CGEM, and AMLX

Should you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include atai Life Sciences (ATAI), Zevra Therapeutics (ZVRA), Tyra Biosciences (TYRA), Maze Therapeutics (MAZE), Valneva (VALN), Septerna (SEPN), aTyr Pharma (ATYR), Mereo BioPharma Group (MREO), Cullinan Therapeutics (CGEM), and Amylyx Pharmaceuticals (AMLX). These companies are all part of the "pharmaceutical products" industry.

FitLife Brands vs. Its Competitors

atai Life Sciences (NASDAQ:ATAI) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

atai Life Sciences presently has a consensus target price of $9.00, indicating a potential upside of 224.32%. FitLife Brands has a consensus target price of $20.50, indicating a potential upside of 45.39%. Given atai Life Sciences' higher probable upside, analysts plainly believe atai Life Sciences is more favorable than FitLife Brands.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
atai Life Sciences
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
FitLife Brands
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

In the previous week, atai Life Sciences had 17 more articles in the media than FitLife Brands. MarketBeat recorded 18 mentions for atai Life Sciences and 1 mentions for FitLife Brands. atai Life Sciences' average media sentiment score of 0.44 beat FitLife Brands' score of 0.00 indicating that atai Life Sciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
atai Life Sciences
6 Very Positive mention(s)
4 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
FitLife Brands
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

FitLife Brands has a net margin of 13.85% compared to atai Life Sciences' net margin of 0.00%. FitLife Brands' return on equity of 25.59% beat atai Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
atai Life SciencesN/A -102.10% -77.55%
FitLife Brands 13.85%25.59%15.26%

atai Life Sciences has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500.

FitLife Brands has higher revenue and earnings than atai Life Sciences. atai Life Sciences is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
atai Life Sciences$310K1,793.37-$149.27M-$0.91-3.05
FitLife Brands$64.47M2.05$8.98M$0.8416.79

28.4% of atai Life Sciences shares are owned by institutional investors. Comparatively, 2.3% of FitLife Brands shares are owned by institutional investors. 26.8% of atai Life Sciences shares are owned by company insiders. Comparatively, 61.3% of FitLife Brands shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

FitLife Brands beats atai Life Sciences on 8 of the 14 factors compared between the two stocks.

Get FitLife Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FTLF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FTLF vs. The Competition

MetricFitLife BrandsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$132.40M$10.19B$5.50B$9.02B
Dividend YieldN/A2.09%5.38%4.10%
P/E Ratio16.7916.7427.5520.29
Price / Sales2.0529.13389.87112.84
Price / Cash13.4322.8436.6357.47
Price / Book3.593.668.075.68
Net Income$8.98M$235.40M$3.17B$249.04M
7 Day Performance10.07%2.15%2.83%3.30%
1 Month Performance-2.49%3.00%3.70%5.20%
1 Year Performance-7.33%-10.21%35.41%21.37%

FitLife Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FTLF
FitLife Brands
4.0709 of 5 stars
$14.10
+3.6%
$20.50
+45.4%
-7.3%$132.40M$64.47M16.7920
ATAI
atai Life Sciences
3.0149 of 5 stars
$2.02
-18.5%
$8.67
+329.0%
+116.8%$496.84M$310K-2.2280Analyst Forecast
Options Volume
High Trading Volume
ZVRA
Zevra Therapeutics
2.7914 of 5 stars
$9.00
-0.4%
$22.29
+147.6%
+127.3%$494.31M$40.59M-4.7420News Coverage
Analyst Forecast
Analyst Revision
TYRA
Tyra Biosciences
1.8354 of 5 stars
$9.71
+5.2%
$30.83
+217.5%
-41.1%$490.02MN/A-5.9620Analyst Forecast
MAZE
Maze Therapeutics
N/A$10.73
-4.0%
$25.67
+139.2%
N/A$489.65M$167.50M0.00121
VALN
Valneva
1.6582 of 5 stars
$5.56
-1.1%
$15.50
+178.8%
-20.5%$478.23M$183.52M-4.67700Positive News
SEPN
Septerna
1.7059 of 5 stars
$10.53
+0.6%
$26.75
+154.0%
N/A$466.52M$977K0.00N/A
ATYR
aTyr Pharma
2.9999 of 5 stars
$4.98
-4.6%
$20.20
+305.6%
N/A$464.60M$230K-6.1553High Trading Volume
MREO
Mereo BioPharma Group
1.9919 of 5 stars
$2.74
-3.9%
$7.60
+177.4%
-19.9%$453.15M$10M-39.1440
CGEM
Cullinan Therapeutics
1.5423 of 5 stars
$7.58
-1.2%
$30.00
+295.8%
-53.5%$452.64MN/A-2.6030
AMLX
Amylyx Pharmaceuticals
3.5177 of 5 stars
$5.02
-0.6%
$10.14
+102.0%
+255.9%$450.16M$87.37M-1.61200

Related Companies and Tools


This page (NASDAQ:FTLF) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners